This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Law Offices Of John David Hart: Stryker Hip Implant Failures Leads To Lawsuit


FORT WORTH, Texas, Sept. 9. 2013 /PRNewswire/ -- A woman recently filed suit against Howmedica Osteonics Corporation d/b/a Stryker Orthopaedics seeking compensation for injuries caused by the failures of her Stryker Rejuvenate Hip Systems for both her left and right hips.  John David Hart of the Law Offices of John David Hart and Ellen Relkin of Weitz & Luxenberg, are the attorneys representing this Plaintiff in the lawsuit filed in the Superior Court of New Jersey, Law Division: Bergen County.

The Stryker Rejuvenate is a modular design hip replacement system that utilizes a titanium neck with a cobalt chromium (CoCr) stem. Unlike other defective metal-on-metal hip replacement systems, the Rejuvenate does not contain metal-on-metal ball and socket components. However, because of the metal-on-metal modular-neck design, patients are still exposed to the risks associated with metal-on-metal articulation. Patients with the Rejuvenate system are reporting many of the same complications as patients with other metal-on-metal hip replacement systems. The Rejuvenate was marketed as providing enhanced stability and flexibility by allowing surgeons to closely match the biomechanics of each patient and by reducing the risk of dislocations and costly revision surgeries.

On July 6, 2012 Stryker voluntarily recalled its Rejuvenate and ABG II modular-neck systems because of complications due to fretting and corrosion at the modular-neck junction. Patients reported complications similar to those seen with other defective metal-on-metal hip replacements including: swelling of the hip and groin, bone staining, nerve, muscle and tissue damage, hip, groin and leg pain and elevated metal ion levels in the bloodstream.

"Many patients have filed lawsuits after their Stryker hip devices failed," said attorney John David Hart.  "The number of people affected by these unsafe devices continues to grow.  We will continue to aggressively seek just and fair compensation for our clients that have been injured as a result of these defective medical devices."

John David Hart and the Law Offices of John David Hart represent individuals in the United States who have been injured as a result of the defective Stryker Rejuvenate and ABG II Hip Systems.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs and medical products, automobile and truck accidents and oil and gas litigation.  For more information, please contact John David Hart at 800.247.1623 or or visit


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs